Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 17/20 | 0.46 |
| ▸ | CTSL | P07711 | 12/20 | 0.46 |
| ▸ | CTSB | P07858 | 3/20 | 0.45 |
| ▸ | CTSK | P43235 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2105960 | 1.00 | CTSS (0.46) | CTSSCTSLCTSBCTSKKMT2A | |
| SCHEMBL697292 | 1.00 | CTSS (0.46) | CTSSCTSLCTSBCTSKKMT2A | |
| SCHEMBL697392 | 0.90 | CTSS (0.45) | CTSSCTSLCTSBCTSKKMT2A | |
| SCHEMBL2102815 | 0.90 | CTSS (0.45) | CTSSCTSLCTSBCTSKKMT2A | |
| SCHEMBL696793 | 0.87 | CTSS (0.53) | CTSSCTSLCTSBCTSK | |
| SCHEMBL2105439 | 0.87 | CTSS (0.53) | CTSSCTSLCTSBCTSK | |
| SCHEMBL2105751 | 0.87 | CTSS (0.43) | CTSSCTSLCTSBCTSKEPHX2 | |
| SCHEMBL696071 | 0.87 | CTSS (0.43) | CTSSCTSLCTSBCTSKEPHX2 | |
| SCHEMBL14975095 | 0.84 | CTSS (0.50) | CTSSCTSLCTSBCTSKEPHX2 | |
| SCHEMBL699370 | 0.84 | CTSS (0.50) | CTSSCTSLCTSBCTSKEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2421826-A1 | PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010121918-A1 | PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-10-28 | — | — | WO | disclosed |